Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.

Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, Schrör K, Hohlfeld T.

Circulation. 2003 Aug 5;108(5):542-7. Epub 2003 Jul 21.

2.
3.

Aspirin "resistance".

Schrör K, Weber AA, Hohlfeld T.

Blood Cells Mol Dis. 2006 Mar-Apr;36(2):171-6. Epub 2006 Feb 15. Review.

PMID:
16469511
4.

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.

Weir MR, Sperling RS, Reicin A, Gertz BJ.

Am Heart J. 2003 Oct;146(4):591-604. Review.

PMID:
14564311
5.

Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.

Wu KK.

Semin Vasc Med. 2003 May;3(2):107-12. Review.

PMID:
15199473
6.

Aspirin resistance: an evaluation of current evidence and measurement methods.

Martin CP, Talbert RL.

Pharmacotherapy. 2005 Jul;25(7):942-53. Review.

PMID:
16006273
7.

Drug insight: aspirin resistance--fact or fashion?

Patrono C, Rocca B.

Nat Clin Pract Cardiovasc Med. 2007 Jan;4(1):42-50. Review.

PMID:
17180149
8.

Mechanisms of aspirin resistance.

Floyd CN, Ferro A.

Pharmacol Ther. 2014 Jan;141(1):69-78. doi: 10.1016/j.pharmthera.2013.08.005. Epub 2013 Aug 29. Review.

PMID:
23993980
9.

Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.

Zimmermann N, Gams E, Hohlfeld T.

Eur J Cardiothorac Surg. 2008 Jul;34(1):93-108. doi: 10.1016/j.ejcts.2008.03.023. Epub 2008 Apr 29. Review.

PMID:
18448350
10.

[Aspirin resistance].

Miyata S, Miyata T, Kada A, Nagatsuka K.

Brain Nerve. 2008 Nov;60(11):1357-64. Review. Japanese.

PMID:
19069170
11.

Aspirin resistance: is this term meaningful?

Violi F, Pignatelli P.

Curr Opin Hematol. 2006 Sep;13(5):331-6. Review.

PMID:
16888437
12.

Effects of nonsteroidal anti-inflammatory therapy on platelets.

Schafer AI.

Am J Med. 1999 May 31;106(5B):25S-36S. Review.

PMID:
10390125
13.

The biochemical pharmacology of thromboxane synthase inhibition in man.

FitzGerald GA, Reilly IA, Pedersen AK.

Circulation. 1985 Dec;72(6):1194-201. Review.

PMID:
3905048
14.

Inhibitors of platelet signal transduction as anti-aggregatory drugs.

Geiger J.

Expert Opin Investig Drugs. 2001 May;10(5):865-90. Review.

PMID:
11322863
15.

Functional testing methods for the antiplatelet effects of aspirin.

Schrör K, Huber K, Hohlfeld T.

Biomark Med. 2011 Feb;5(1):31-42. doi: 10.2217/bmm.10.122. Review.

PMID:
21319963
16.

Current issues in thrombosis prevention with antiplatelet drugs.

de Gaetano G, Cerletti C, Dejana E, Vermylen J.

Drugs. 1986 Jun;31(6):517-49. Review.

PMID:
3525085
17.

Clinical pharmacology of platelet cyclooxygenase inhibition.

Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, Davì G, Forni L.

Circulation. 1985 Dec;72(6):1177-84. Review.

PMID:
3933848
18.

Anti-platelet therapy and aspirin resistance - clinically and chemically relevant?

Rafferty M, Walters MR, Dawson J.

Curr Med Chem. 2010;17(36):4578-86. Review.

PMID:
21062249
19.

Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.

de Gaetano G, Cerletti C, Dejana E, Latini R.

Circulation. 1985 Dec;72(6):1185-93. Review.

PMID:
2998640
20.

Inhibition of platelet aggregation as a surrogate marker.

Narjes H, Müller TH, Weisenberger H, Guth B, Brickl R.

J Clin Pharmacol. 1997 Jan;37(1 Suppl):59S-64S. Review.

PMID:
9048286

Supplemental Content

Support Center